Company intelligence / Profile preview

Infinite Biomedical Technologies

Baltimore, Maryland, United Statesi-biomed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Infinite Biomedical Technologies has commercialized multiple FDA-cleared and CE-marked medical devices for upper limb prosthetics. Their Glide platform offers advanced myoelectric control for prostheses using machine learning algorithms to improve function and user experience. The company’s products are available in 21 countries and have served over 5,000 patients. They have received significant grant funding from DARPA, NSF, NIH and others to support R&D without external equity or debt.

Therapeutic areas: Other
Modalities: Device
Industry: Assistive Medical Devices

Partnerships

Hanger Clinic (collaboration on grants/clinical trials for the Glide platform)

Beyond the preview

Go deeper on Infinite Biomedical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infinite Biomedical Technologies.

Explore the full profile